XML 15 R6.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Corporate Information | 6 Months Ended
--- | ---
Jun. 30, 2022
Corporate Information |
Corporate Information | 1. Corporate Information CureVac N.V. (“CureVac” or “CV” or the “Company”) is the parent company of CureVac Group (“Group”) and, along with its subsidiaries, is a global biopharmaceutical company developing a new class of transformative medicines based on the messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. The Company is incorporated in the Netherlands and is registered in the commercial register at the Netherlands Chamber of Commerce under RSIN 861149336. The Company’s registered headquarters is Friedrich-Miescher-Strasse 15, 72076 Tuebingen, Germany. During 2021 until now, Dievini Hopp BioTech holding GmbH & Co. KG (dievini), which is an investment company dedicated to the support of companies in health and life sciences, is the largest shareholder of CureVac. Together with its related parties, dievini has held shares and voting rights in CureVac between appr. 46 – 49 % during that period. dievini is thus considered to be the de facto parent of the Group. Dietmar Hopp, Daniel Hopp and Oliver Hopp are the ultimate controlling persons (of the main shareholders) of dievini, and, therefore, control the voting and investment decisions of dievini.

X
- References No definition available. + Details
Name: | cvac_CorporateInformationAbstract
Namespace Prefix: | cvac_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure on corporate information. + References No definition available. + Details
Name: | cvac_CorporateInformationTextBlock
Namespace Prefix: | cvac_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration